Lumina Pharmaceuticals Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-20.
Lumina Pharmaceuticals Inc. filed a Form D notice of an exempt securities offering with the SEC on June 20, 2025. The filing reports $2M sold. Its industry group is Pharmaceuticals. It names Alma Sorensen (Executive Officer, Director), Peter Caravan (Director), Cara Ferreira (Executive Officer, Director) (SEC Form D, June 20, 2025).
Is this your company?
Sell to companies like Lumina Pharmaceuticals Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lumina Pharmaceuticals Inc.
Free to see. No signup.
More on the people and the money behind Lumina Pharmaceuticals Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed in June 2025, largest first.
Get an email when Lumina Pharmaceuticals Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lumina Pharmaceuticals Inc. raises, hires or launches. No email unless you switch it on.
Watch Lumina Pharmaceuticals Inc. →Get the full cited report on Lumina Pharmaceuticals Inc.
What the filing shows about Lumina Pharmaceuticals Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lumina Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lumina Pharmaceuticals Inc.'s address as 1 Huntington Ave. #1802, Boston, MA 02116.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Lumina Pharmaceuticals Inc. See pricing
Lumina Pharmaceuticals Inc. is a registered filer with the SEC (CIK 2069952) and has filed since 2025-06-20. 1 filing is on record, the latest on 2025-06-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lumina Pharmaceuticals Inc.'s Form D of 2025-06-20 names Alma Sorensen, Peter Caravan and Cara Ferreira as its officers, directors or promoters.
Its new offerings report $2M sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Alma Sorensen is named as Executive Officer and Director on the Form D that Lumina Pharmaceuticals Inc. filed with the SEC on 20 June 2025, one of 3 people that filing names.
Peter Caravan is named as Director on the Form D that Lumina Pharmaceuticals Inc. filed with the SEC on 20 June 2025, one of 3 people that filing names.
Cara Ferreira is named as Executive Officer and Director on the Form D that Lumina Pharmaceuticals Inc. filed with the SEC on 20 June 2025, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2025-06-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Lumina Pharmaceuticals Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lumina Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lumina Pharmaceuticals Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lumina Pharmaceuticals Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lumina Pharmaceuticals Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Lumina Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/lumina-pharmaceuticals-inc-form-d-25000001